
Cefotaz S 250mg/125mg Injection
Marketer
V Care Biotech
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Cefotaz S 250mg/125mg Injection
Ceftriaxone and Sulbactam 250mg/125mg Injection is a dual-action antibiotic. It's indicated for a range of bacterial infections, inhibiting microbial growth and halting infection progression. Administration must be solely under a doctor's guidance. Strictly adhere to the prescribed dosage schedule; complete the full course, regardless of symptom improvement. Premature cessation may compromise treatment effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; contact your physician if these worsen. Seek immediate medical attention for allergic reactions such as rash, itching, swelling, or respiratory distress. Inform your doctor of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals require medical consultation before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Prioritize rest, balanced nutrition, and sufficient hydration for optimal recovery. Your doctor may order tests to monitor treatment efficacy.
Primary Ingredients of Cefotaz S 250mg/125mg Injection
No text provided to rephrase.
Uses of Cefotaz S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Cefotaz S 250mg/125mg Injection:
Administering this medication will be handled by your physician or their qualified associate; self-medication is strictly prohibited.
Common Side effects of Cefotaz S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefotaz S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Cefotaz S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Cefotaz S 250mg/125mg Injection, offer a dual-action approach to bacterial infections. Ceftriaxone, a crucial antibiotic component, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam's role as a beta-lactamase inhibitor counters bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Cefotaz S 250mg/125mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefotaz S, at doses of 250mg/125mg, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
The administration of Cefotazime 250mg/125mg injection to breastfeeding mothers requires careful consideration. It's advised to discontinue breastfeeding for the duration of the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Cefotazime 250mg/125mg injection may induce drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefotaz S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Exercise caution when administering Cefotaz S 250mg/125mg Injection to individuals suffering from severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Cefotaz S 250mg/125mg Injection is unnecessary in patients with mild or moderate liver dysfunction.
What if you forget to take Cefotaz S 250mg/125mg Injection :
Should you forget a dose of Cefotazime 250mg/125mg injection, seek your physician's advice.
Facts to Know About Cefotaz S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
